Skip to main content
Satish Nagula, MD, Gastroenterology, New York, NY

Satish Nagula MD

Advanced Endoscopic Interventional


Associate Professor of Medicine ; Program Director, Gastroenterology Fellowship

Join to view full profile
  • 17 E 102nd StNew York, NY 10029

  • Phone+1 212-241-8100

  • Fax+1 646-537-8921

Dr. Nagula is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Satish Nagula is a gastroenterologist in New York, NY and is affiliated with Mount Sinai Hospital. He received his medical degree from Yale University School of Medicine and has been in practice 14 years. He specializes in advanced endoscopic interventional and is experienced in interventional gastroenterology.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Gastroenterology, 2006 - 2009
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Internal Medicine, 2003 - 2006
  • Yale School of Medicine
    Yale School of MedicineClass of 2003

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2006 - 2028
  • PA State Medical License
    PA State Medical License 2003 - 2006
  • Gastroenterology
    American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification PowerChart (Clinical), Cerner Corporation, 2013, 2015, 2017
  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013, 2015, 2017
  • CMS Meaningful Use Stage 1 Certification PowerChart, Cerner Healthe, Cerner Patient Portal, HealthSentry and P2 Sentinel, Cerner Corporation, 2013, 2015, 2017

Clinical Trials

Publications & Presentations

PubMed

Authored Content

  • Successful Creation of Pancreatic Cancer Organoids by Means of EUS-Guided Fine-Needle Biopsy for Personalized Cancer TreatmentJanuary 2018

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: